Edition:
United States

Mauna Kea Technologies SAS (MKEA.PA)

MKEA.PA on Paris Stock Exchange

2.16EUR
11:12am EDT
Change (% chg)

€-0.01 (-0.46%)
Prev Close
€2.17
Open
€2.17
Day's High
€2.17
Day's Low
€2.13
Volume
30,594
Avg. Vol
145,035
52-wk High
€4.53
52-wk Low
€1.57

Select another date:

Wed, Aug 2 2017

BRIEF-Mauna Kea Technologies: multicenter randomized controlled trial shows improved early stomach cancer detection with Cellvizio

* SAYS MULTICENTER RANDOMIZED CONTROLLED TRIAL SHOWS IMPROVED EARLY STOMACH CANCER DETECTION WITH CELLVIZIO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Mauna Kea Technologies announces benefits of using Cellvizio for characterizing upper urinary tract cancer

* MAUNA KEA TECHNOLOGIES: NEW PUBLICATION CONFIRMS BENEFITS OF USING CELLVIZIO FOR CHARACTERIZING UPPER URINARY TRACT CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Mauna Kea Technologies announces new peer-reviewed publication on Cellvizio

* Mauna Kea Technologies announces new peer-reviewed publication reports further external validation of unmatched Cellvizio endomicroscopy performance and inter-observer agreement in the characterization of pancreatic cysts

Select another date: